Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the safety profile in healthy adult volunteers of single or multiple intravenous administrations of TCN-202 as compared with placebo.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Theraclone Sciences, Inc.
NCT05234723 · Cytomegalovirus Infections
NCT07294547 · Kidney Transplantation, Cytomegalovirus Infections, EBV Infection, and more
NCT06909110 · Adenovirus, Cytomegalovirus Infections, and more
NCT03266640 · Cytomegalovirus Infections, Primary Immune Deficiency Disorder
NCT06926894 · Epstein-Barr Virus, Cytomegalovirus Infections, and more
SNBL Clinical Pharmacology Center
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions